Aprepitant capsules and Lidocaine and Prilocaine cream Recall

by

Published by Reclia Safety Desk | July 19, 2026

📌 Recall Notice

Product: Aprepitant capsules and Lidocaine and Prilocaine cream

Brand: Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream)

Hazards: Chemical Risk

What to do: Stop using this product. Follow the recall instructions for refund or replacement.

Official US CPSC Recall Notice
Recall #9556 |
View original notice →

Recall Summary

Product Aprepitant capsules and Lidocaine and Prilocaine cream
Brand Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream)
Category Toys Children
Recall Number 9556
Hazard Chemical Risk
Units Affected Not specified
Recall Date March 09, 2023
Remedy Contact manufacturer
Country 🇺🇸 United States

Recall Information Record
Database Entry ID: 9556
Recall Number: 23146
Date Posted: 2023-03-09

—

1. Recall Summary
Sandoz Inc. is recalling specific lots of Aprepitant Capsules 125 mg and Lidocaine and Prilocaine Cream 2.5%/2.5% prescription drugs. The recall is due to the products’ failure to meet the child-resistant packaging requirement under the Poison Prevention Packaging Act (PPPA). The products were sold nationwide at pharmacies as prescribed medicines from October 2020 through January 2023. Approximately 156,750 units are affected.

2. Affected Products
The recall involves two prescription drug products:

– Aprepitant Capsules 125 mg: Sold in cartons containing one blister card of 6 capsules. The blister card is non-child resistant. The carton bears the name “Sandoz,” the medication name, dosage, NDC number, lot number, and expiration date. The warnings “This unit-dose packaging is not child-resistant” and “For institutional use only” are printed on the carton.
– NDC Numbers: 0781-2323-68 (Carton of 1 Blister Pack of 6 capsules); 0781-2323-06 (Blister Pack)
– Lot Numbers: LK3209, LC6454
– Expiration Dates: 04/2024, 12/2023

– Lidocaine and Prilocaine Cream 2.5%/2.5%: Sold in 5 gram tubes with a continuous thread white closure. The carton and tube bear the name “fougera®,” the medication name, dosage, and NDC number. The expiration date and lot number are printed on the carton and stamped on the crimp of the tube. The warning “FOR HOSPITAL USE ONLY” is printed on the carton and tube.
– NDC Numbers: 0168-0357-56 (Carton of 5 tubes and 12 dressings); 0168-0357-55 (Carton of 5 tubes); 0168-0357-05 (Tube)
– Lot Numbers: LA2782, LA2784, LV0667, LX5350, MA1640, MB3205, LA2785, LR9041, MB3209
– Expiration Dates: 03/2023, 03/2023, 02/2024, 03/2024, 03/2024, 04/2024, 03/2023, 11/2023, 04/2024

3. Hazard Information
The recalled prescription drugs are required by the Poison Prevention Packaging Act (PPPA) to be in child-resistant packaging. The packaging of these products is not child resistant. This poses a risk of poisoning if the contents are swallowed by young children. No injuries have been reported in connection with this recall.

4. Consumer Action Required
Consumers who have any of the recalled products should immediately secure the medications out of the sight and reach of children. Consumers should then contact Sandoz to request a free child-resistant pouch to store the products. Once the medication is secured in the pouch, consumers can continue to use the medication as directed.

5. Official Remedy
The official remedy offered by Sandoz is the provision of a free child-resistant pouch to store the recalled products. Consumers are instructed to use this pouch to secure the medication. No refund, replacement product, or return of the medication is required. Consumers may continue using the medication after securing it in the provided pouch.

6. Contact Information
– Phone: Sandoz toll-free at 866-300-2207, available from 8 a.m. to 5 p.m. ET Monday through Friday.
– Email: Sandoz6768@sedgwick.com
– Website: https://www.us.sandoz.com/patients-customers/product-safety-notices or visit www.us.sandoz.com and click on “Product Safety Notices” below the carousel for more information.

Recall Timeline

  • **March 09, 2023** – Recall announced by CPSC (Source)
  • **Current** – Consumers advised to stop using product
  • **Ongoing** – Refund or replacement available

Frequently Asked Questions

Q: How do I identify the recalled Aprepitant capsules and Lidocaine and Prilocaine cream?

A: Check the model and serial number on your product against the official recall notice (#9556).

Q: What should I do if I own the recalled Aprepitant capsules and Lidocaine and Prilocaine cream?

A: The recall notice advises consumers to stop using the product and follow the recall instructions.

Q: How do I get a refund or replacement for the recalled Aprepitant capsules and Lidocaine and Prilocaine cream?

A: Contact the manufacturer using the information in the recall notice.

Related Recalls (Click to expand)

Disclaimer: Information on this page is summarized from official recall notices.
Reclia is a recall information database and does not conduct product testing, safety certification,
or independent investigations.

Consumers should refer to the original recall notice
for complete details and official instructions.




Leave a Comment